Advertisement

Side-effects of natural prostaglandins

  • T. H. Lippert
Part of the Advances in Reproductive Health Care book series (ARHE, volume 4)

Abstract

Although there is great interest in making clinical use of the diverse Prostaglandin (PG) actions, it cannot be overlooked that they are also able to produce undesirable side-effects. Thus, it is important to recognize and be prepared for the pharmacological and toxicological actions of PGs in their therapeutic use.

Keywords

Uterine Rupture Pathological Aspect Fertility Regulation Therapeutic Abortion Trimester Abortion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson, G. G. and Steege, J. F. (1975). Clinical experience using intraamniotic Prostaglandin F for midtrimester abortion in 600 patients. Obstet. Gynecol., 46, 591PubMedCrossRefGoogle Scholar
  2. Baile, C. A., Martin, F. H., Forbes, J. M., Webb, R. L. and Kingsbury, W. (1974). Intrahypothalamic injections of Prostaglandins and Prostaglandin antagonists and feeding in sheep. J. Dairy Sci., 57, 81PubMedCrossRefGoogle Scholar
  3. Bennett, A. (1976). Prostaglandins and the alimentary tract. In Karim, S. M. M. (ed.). Prostaglandins: Physiological, Pharmacological and Pathological Aspects, p. 247. ( Lancaster: MTP Press )Google Scholar
  4. Borten, M. and Friedman, E. A. (1978). Uterine rupture: a complication of midtrimester abortion. Prostaglandins, 15, 187CrossRefGoogle Scholar
  5. Brash, J. H. (1976). A generalized epileptiform convulsion after intra-amniotic Prostaglandin E2. Br. J. Obstet. Gynaecol., 83, 665PubMedCrossRefGoogle Scholar
  6. Brenner, W. E., Dingfelder, J. R., Hendricks, C. H. and Staurovsky, L. G. (1973). Introduction of therapeutic abortion with a single dose of intra-amniotically administered Prostaglandin F. Prostaglandins, 4, 485CrossRefGoogle Scholar
  7. Bromham, D. R. and Anderson, R. S. (1980). Uterine scar rupture in labour induced with vaginal Prostaglandin E2. Lancet, 2, 485PubMedCrossRefGoogle Scholar
  8. Burt, R. L., Connor, E. D. and Davidson, I. W. F. (1977). Hypokalemia and cardiac arrhythmia associated with prostaglandin-induced abortion. Obstet. Gynecol., 50, 45Google Scholar
  9. Bygdeman, M., Bremme, K., Gillespie, A. and Lundström, V. (1979). Effects of the pros-taglandins on the uterus. Acta Obstet. Gynecol. Scand., Suppl. 87, 33Google Scholar
  10. Cates, W. and Jordaan, H. V. F. (1979). Sudden collapse and death of women obtaining abortions induced with Prostaglandin F. Am. J. Obstet. Gynecol., 133, 398PubMedGoogle Scholar
  11. Cates, W., Grimes, D. A., Haber, R. J. and Tyler, C. W. (1977). Abortion death associates with the use of Prostaglandin F. Am. J. Obstet. Gynecol., 127, 219PubMedGoogle Scholar
  12. Coceani, F. and Pace-Asciak, C. R. (1976). Prostaglandins and the central nervous system. In Karim, S. M. M. (ed.). Prostaglandins: Physiological Pharmacological and Pathological Aspects, p. 1 ( Lancaster: MTP Press )Google Scholar
  13. Eklund, B. and Carlson, L. A. (1980). Central and peripheral circulatory effects and metabolic effects of different Prostaglandins given i.v. to man. Prostaglandins, 20, 333PubMedCrossRefGoogle Scholar
  14. Embrey, M. P. (1975). Prostaglandin-induced Abortion and Cervical Incompetence. Br. Med. J., 2, 497PubMedCrossRefGoogle Scholar
  15. Faden, A., Golbus, M. S. and Spire, J. P. (1976) Electroencephalographic changes following intraamniotic Prostaglandin F administration for therapeutic abortion. Obstet. Gynecol., 47, 607PubMedGoogle Scholar
  16. Fishburne, J. I., Brenner, W. E., Braaksma, J. T., Staurovsky, L. G. Mueller, R. A., Hoffer, J. L. and Hendricks, C. H. (1972). Cardiovascular and respiratory responses to intravenous infusion of Prostaglandin F in the pregnant woman. Am. J. Obstet. Gynecol., 114, 765PubMedGoogle Scholar
  17. Fraser, I. S. (1974). Complications of Prostaglandin-induced Abortion. Br. Med. J., 4, 404Google Scholar
  18. Fraser, I. S. and Brash, J. H. (1974). Comparison of extra- and intra-amniotic Prostaglandins for therapeutic abortion. Obstet. Gynecol., 43, 97PubMedGoogle Scholar
  19. Fraser, I. S. and Gray, C. (1974). Prostaglandin F and electroencephalogram changes. Lancet, 2, 49PubMedCrossRefGoogle Scholar
  20. Göretzlehner, A. and Klausen, B. (1974). Transverse posterior cervical rupture following extra-amniotic Prostaglandin F-induced abortion. Am. J. Obstet. Gynecol., 119, 865PubMedGoogle Scholar
  21. Greaves, M. W. (1976). Prostaglandins and inflammation. In Karim, S. M. M. (ed.). Prostaglandins: Physiological, Pharmacological and Pathological Aspects, p. 293. ( Lancaster: MTP Press )Google Scholar
  22. Haller, U. and Kubli, F. (1978). Klinische Nebenwirkungen und Komplikationen der Prostaglandine bei Abortinduktion. Gynäkologie, 11, 39Google Scholar
  23. Howie, P. W. (1976). Prostaglandins and blood-coagulation. In Karim, S. M. M. (ed.). Prostaglandins: Physiological, Pharmacological and Pathological Aspects, p. 277. ( Lancaster: MTP Press )Google Scholar
  24. Hunt, R. H., Dilawari, J. B. and Misiewicz, J. J. (1975). The effect of intravenous Prostaglandin F2a and E2 on the motility of the sigmoid colon. Gut, 16, 47PubMedCrossRefGoogle Scholar
  25. Hyman, A. L., Spannhake, E. W. and Kadowitz, P. J. (1978). Prostaglandins and the lung. Am. Rev. Resp. Dis., 117, 111PubMedGoogle Scholar
  26. Kajanoja, P., Jungner, G., Wildholm, O., Karjalainen, O. and Seppälä, M. (1974). Rupture of the cervix in Prostaglandin abortions. J. Obstet. Gynaecol. Br. Commonw., 81, 242PubMedCrossRefGoogle Scholar
  27. Kaplan, E. (1978). A generalized epileptiform convulsion after intra-amniotic Prostaglandin with intravenous Oxytocin infusion: a case report. S. Afr. Med. J., 53, 27PubMedGoogle Scholar
  28. Karim, S. M. M. (1974). Adverse reactions to intra-amniotic Prostaglandin. Br. Med. J., 3, 347PubMedCrossRefGoogle Scholar
  29. Karim, S. M. M. and Hillier, K. (1975). Physiological roles and pharmacological actions of Prostaglandins in relation to human reproduction. In Karim, S. M. M. (ed.). Prostaglandins and Reproduction, p. 23. ( Lancaster: MTP Press )Google Scholar
  30. Lewis, G. P. (1975). The Role of Prostaglandins in Inflammation, p. 161. (Bern: Hans Huber Publishers)Google Scholar
  31. Lippert, T. H. (1977). Die Prostaglandine in der reproduktiven Physiologie. Klin. Wochenschr., 55, 515PubMedCrossRefGoogle Scholar
  32. Lowensohn, R. and Ballard, C. A, (1974). Cervicovaginal fistula: an apparent increased incidence with Prostaglandin F. Am. J. Obstet. Gynecol., 119, 1057PubMedGoogle Scholar
  33. Lyneham, R. C., McLeod, J. G., Smith, I. D., Low, P. A., Shearman, R. P. and Korda, A. R. (1973). Convulsions and electroencephalogram abnormalities after intra-amniotic pros-taglandin F Lancet, 2, 1003CrossRefGoogle Scholar
  34. MacKenzie, I. Z. and Hillier, K. (1977). Prostaglandin-induced abortion and outcome of subsequent pregnancies: a prospective controlled study. Br. Med. J., 2, 1114PubMedCrossRefGoogle Scholar
  35. MacKenzie, I. Z., Hillier, K. and Embrey, M. P. (1973). Convulsions and prostaglandin-induced abortion. Lancet, 2, 1323PubMedCrossRefGoogle Scholar
  36. Malik, K. U. and McGiff, J. C. (1976). Cardiovascular Actions of Prostaglandins. In Karim, S. M. M. (ed.). Prostaglandins: Physiological, Pharmacological and Pathological Aspects, p. 103 ( Lancaster: MTP Press )Google Scholar
  37. McCarthy, T. and McQueen, J. (1980). Uterine rupture as a complication of second trimester abortion using intraamniotic Prostaglandin E2 and augmentation with other oxytocic agents. Prostaglandins, 19, 849PubMedCrossRefGoogle Scholar
  38. Moneada, S., Flower, R. J. and Vane, J. R. (1980). Prostaglandins, prostacyclin and thromboxane A2. In Goodman, L. S. and Gilman, A. (eds.). The Pharmacological Basis of Therapeutics, p. 668 ( New York: Macmillan )Google Scholar
  39. Neeb, U. (1980). Wirksamkeit und Nebenwirkungen der intrazervikalen Prostaglandin F-Gel Applikation im 1.Trimenon. Geburtsh. u. Frauenheilk., 40, 901CrossRefGoogle Scholar
  40. Patterson, S. P., White, J. H. and Reaves, E. M. (1979). A maternal death associated with Prostaglandin E2. Obstet. Gynecol., 54, 123PubMedCrossRefGoogle Scholar
  41. Perry, G., Siegal, B. and Held, B. (1977). Uterine trauma associated with midtrimester abortion induced by intra-amniotic Prostaglandin F, with and without concomitant use of Oxytocin. Prostaglandins, 13, 1147PubMedCrossRefGoogle Scholar
  42. Phelan, J. P., Meguiar, R. V., Matey, D. and Newman, C. (1978). Dramatic pyrexic and cardiovascular response to intravaginal Prostaglandin E2. Am. J. Obstet. Gynecoi., 132, 28Google Scholar
  43. Purandare, V. N., Ganguli, A. C., Gharse, R. M. and Krishna, U. R. (1977). Cervico-vaginal injuries in cases of second trimester termination of pregnancy. Prostaglandins, 13, 349PubMedCrossRefGoogle Scholar
  44. Robert, A. (1976). Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of Prostaglandins. In Samuelsson B. and Paoletti, R. (eds.). Advances in Prostaglandin and Thromboxane Research, Vol. 2, p. 507. ( New York: Raven Press )Google Scholar
  45. Roberts, G. and Turnbull, A. C. (1971). Uterine hypertonus during labour induced by Prostaglandins. Br. Med. J., 1, 702PubMedCrossRefGoogle Scholar
  46. Roberts, G., Mottram, R. F., Parry, H and Bloom, A (1972). Cyanosis due to intravenous Prostaglandin F. Lancet, 2, 425PubMedCrossRefGoogle Scholar
  47. Ross, A. H. and Whitehouse, W. L. (1974). Adverse reactions to intra-amniotic urea and Prostaglandin. Br. Med. J., 1, 642PubMedCrossRefGoogle Scholar
  48. Sandier, R. Z., Knutzen, V. K., Milano, C. M. and Gleicher, N. (1979). Uterine rupture with the use of vaginal Prostaglandin E2 suppositories. Am. J. Obstet. Gynecol., 134, 348Google Scholar
  49. Shearman, R. P., Lyneham, R. C., Walsh, J. C. Itzkowic, D. and Shutt, D. A. (1975). Elektroencephalographic changes after intraamniotic Prostaglandin F and hypertonic saline. Br. J. Obstet. Gynaecol., 82, 314PubMedCrossRefGoogle Scholar
  50. Smith, A. M. (1974). Adverse reactions to intra-amniotic Prostaglandin. Br. Med. J., 2, 382CrossRefGoogle Scholar
  51. Smith, A. P. (1973a). Side-effects of Prostaglandins. Lancet, 2, 655Google Scholar
  52. Smith, A. P. (1973b). The effects of intravenous infusion of graded doses of Prostaglandins F and E2 on lung resistance in patients undergoing termination of pregnancy. Clin. Sci., 44, 17PubMedGoogle Scholar
  53. Smith, A. P. (1976). Prostaglandins and the Respiratory System. In Karim, S. M. M. (ed.). Prostaglandins: Physiological Pharmacological and Pathological Aspects, p. 83 ( Lancaster: MTP Press )Google Scholar
  54. Smith, E. R. and Mason, M. M. (1974). Toxicology of the Prostaglandins. Prostaglandins, 7, 247PubMedCrossRefGoogle Scholar
  55. Thiery, M. and Amy, J. J. (1976). Uterine hypertonus after induction of labour with Prostaglandin E2 tablets. Br. Med. J., 1, 958PubMedCrossRefGoogle Scholar
  56. Thiery, M., Amy, J. J., Hemptinne de D. and Yo Le Sian (1974). Prostaglandins and convulsions. Lancet, 1, 218PubMedCrossRefGoogle Scholar
  57. Toppozada, M., Gaafar, A., Shaala, S. and Osman, M. (1975). The relaxant property of local Prostaglandin E2 on the non-pregnant uterus-a cyclic response. Prostaglandins, 9, 475PubMedCrossRefGoogle Scholar
  58. Van Der Plaetsen, L., Thiery, M., Amy, J. J. and Hemptinne de D. (1974). Effect of Prostaglandin E2 therapy on the cerebral cortex. Lancet, 1, 1226PubMedCrossRefGoogle Scholar
  59. Ylöstalo, P., Kauppila, E. and Vapaatalo, H. (1974). Complications following the intra-amniotic administration of Prostaglandin F for therapeutic abortion. Acta Obstet. Gynecol. Scand., 53, 279PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1984

Authors and Affiliations

  • T. H. Lippert

There are no affiliations available

Personalised recommendations